Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus.

After 8 weeks of finerenone treatment, there was no significant difference in blood glucose and heart weight to body weight ratio, and blood lipids seemed to increase, but this difference did not reach statistical significance (Table 1 ).

also in 111,027 other papers